These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12853696)

  • 1. Life-threatening bleeding from refractory acquired FVIII inhibitor successfully treated with rituximab.
    Jy W; Gagliano-DeCesare T; Kett DH; Horstman LL; Jimenez JJ; Ruiz-Dayao Z; Santos ES; Ahn YS
    Acta Haematol; 2003; 109(4):206-8. PubMed ID: 12853696
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired high-titer factor VIII inhibitor: fatal bleeding despite multimodal treatment including rituximab preceded by multiple plasmaphereses.
    Fischer KG; Deschler B; Lübbert M
    Blood; 2003 May; 101(9):3753-4; author reply 3754-5. PubMed ID: 12707227
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab in the treatment of acquired factor VIII inhibitors.
    Wiestner A; Cho HJ; Asch AS; Michelis MA; Zeller JA; Peerschke EI; Weksler BB; Schechter GP
    Blood; 2002 Nov; 100(9):3426-8. PubMed ID: 12384448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired inhibitors.
    Cohen AJ; Kessler CM
    Baillieres Clin Haematol; 1996 Jun; 9(2):331-54. PubMed ID: 8800509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab for the treatment of high titre inhibitors in mild haemophilia A.
    Dolničar MB; Rajić V; Kitanovski L; Debeljak M
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s345-7. PubMed ID: 23522890
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired hemophilia.
    Bouvry P; Recloux P
    Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bullous pemphigoid and acquired haemophilia].
    Kluger N; Navarro R; Pallure V; Guillot B
    Ann Dermatol Venereol; 2011 May; 138(5):422-3. PubMed ID: 21570569
    [No Abstract]   [Full Text] [Related]  

  • 8. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
    Holme PA; Brosstad F; Tjønnfjord GE
    Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intracranial bleeding in acquired hemophilia].
    Marquardt L; Haubelt H; Gass S; Grau AJ
    Nervenarzt; 2006 Dec; 77(12):1480-2. PubMed ID: 17102990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literature.
    Biss TT; Velangi MR; Hanley JP
    Haemophilia; 2006 May; 12(3):280-4. PubMed ID: 16643214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of high-dose intravenous gamma globulin therapy in acquired von Willebrand's disease.
    van Genderen PJ; Michiels JJ; Bakker JJ; van 't Veer MB
    Vox Sang; 1994; 67(1):14-7. PubMed ID: 7975445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia.
    Tay L; Duncan E; Singhal D; Al-Qunfoidi R; Coghlan D; Jaksic W; Szabo F; McRae S; Lloyd J
    Semin Thromb Hemost; 2009 Nov; 35(8):769-77. PubMed ID: 20169513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of life-threatening head and neck hemorrhage after dental extractions: a case report.
    Lieberman BL; Kennedy MK; Lorenzo DR; Reed LJ; Adamo AK; Cardo VA; Badner VM
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2311-9. PubMed ID: 20728036
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-term response to rituximab in a patient with acquired hemophilia].
    García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
    Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
    Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F
    Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820
    [No Abstract]   [Full Text] [Related]  

  • 18. Acquired hemophilia A: clinical features, surgery and treatment of 34 cases, and experience of using recombinant factor VIIa.
    Lak M; Sharifian RA; Karimi K; Mansouritorghabeh H
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):294-300. PubMed ID: 19211581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
    Field JJ; Fenske TS; Blinder MA
    Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders.
    Federici AB
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S48-58. PubMed ID: 16427386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.